| Anecdotal
Cases
Anecdotal Case 1
Report Date: 8/25/02
Patient: J.H , 48 years old, CFS since 1991
Clinic: Clymer Healing Research Center
5916 Clymer Road
Quakertown, PA 18951
Dr Poesnecker ND, DC
Product: NatCell® CF Support, 24-day protocol
Observed results for the starting dose and supporting dose:
Immediate improvement in overall muscle weakness
Gradual improvement was noticed in the following areas:
Observed results for the Maximum dose:
Improvements listed above processed
· During three out of the eight days, she experienced
anxiety and agitation throughout the day.
· After completion of the 24-day cycle, the improvements
were maintained for 7-10 days, with symptoms gradually
returning to prior levels.
Observed results on maintenance program (1 vial per
week):
Anecdotal
Case 2
CF-Support
48 year old menopaused patient (by hysterectomy) 5 years ago
following a fibroma. No other antecedent requiring
surgery. Two normal pregnancies (23 and 28 years old).
Suffered from slight hypertension in 1992 following a job
loss. No medication was necessary. In 1999,
suffered from diffused muscular pains, insomnia, weight loss
and asthenia.
Diagnosis: fibromyalgia.
In 2000, constant fatigue and slight anaemia.
Diagnosis: chronic fatigue.
She took iron supplements, hormonotherapy
and Paxil (for a 3 months period). In 2001, hormonotherapy
ceased. Fatigue and pain persisted.
This patient has a vegetarian diet and exercises regularly.
She has a stressing job (accountant).
In January 2002, slight improvement of the general health
following a treatment of adrenal extracts pills, anti-oxidants
and a PH adjustment.
In May 2002, introduction of CF-Support.
First week: no improvement.
2nd week: less pain, improved
sleep, energy level more stable.
3rd week: progression of
energy level.
Following the treatment, the energy level
of this patient has improved 60 to 70%.
Up to now, the energy level seems to remain stable.
Autumn could bring some changes.
<:::Back
| Table
of Contents | Next:::>
2003
Atrium Biotechnologies Inc. All Rights Reserved 4/19
©CF Support Scientific Review |
